Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,860,186
  • Shares Outstanding, K 149,746
  • Annual Sales, $ 876,290 K
  • Annual Income, $ -83,990 K
  • 60-Month Beta 1.88
  • Price/Sales 14.34
  • Price/Cash Flow N/A
  • Price/Book 4.94

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.60
  • Number of Estimates 8
  • High Estimate -0.27
  • Low Estimate -0.99
  • Prior Year -0.30
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
73.11 +17.47%
on 05/04/20
89.05 -3.56%
on 05/18/20
+4.89 (+6.04%)
since 04/29/20
3-Month
35.25 +143.62%
on 03/18/20
89.05 -3.56%
on 05/18/20
+4.93 (+6.09%)
since 02/28/20
52-Week
35.25 +143.62%
on 03/18/20
123.99 -30.74%
on 07/30/19
-11.84 (-12.12%)
since 05/29/19

Most Recent Stories

More News
Exact Sciences Showcases Continued Progress in Cancer Diagnostics at ASCO 2020

, /PRNewswire/ --Exact Sciences Corp. (NASDAQ: EXAS) today announced it is presenting new data at the 2020 American Society of Clinical Oncology (ASCO20) Virtual Scientific Program. These data further...

EXAS : 85.88 (+2.37%)
Exact Sciences to participate in June investor conferences

, /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors to participate by webcast.

EXAS : 85.88 (+2.37%)
After Yesterday's Decline of 1.57%, Exact Sciences Offers Investors Better Value

Exact Sciences (NASDAQ:EXAS) traded in a range yesterday that spanned from a low of $81.87 to a high of $84.66. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $83.83...

EXAS : 85.88 (+2.37%)
Watch for Exact Sciences to Potentially Pullback After Gaining 2.37% Yesterday

Exact Sciences (NASDAQ:EXAS) traded in a range yesterday that spanned from a low of $83.15 to a high of $86.72. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of...

EXAS : 85.88 (+2.37%)
Exact Sciences' (EXAS) Q1 Earnings Fall Y/Y, Margin Expands

Exact Sciences' (EXAS) first-quarter 2020 results reflect strong performance by Screening segment amid the coronavirus-led economic crisis.

BIIB : 307.09 (+2.19%)
LLY : 152.95 (+1.53%)
EXAS : 85.88 (+2.37%)
APHA : 4.23 (-1.86%)
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) delivered earnings and revenue surprises of -5.26% and 0.07%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

EXAS : 85.88 (+2.37%)
Exact Sciences: 1Q Earnings Snapshot

MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Wednesday reported a loss of $105.7 million in its first quarter.

EXAS : 85.88 (+2.37%)
Exact Sciences Announces First Quarter 2020 Results

, /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of for the first quarter ended Mar. 31, 2020, compared to for the same period of 2019.

EXAS : 85.88 (+2.37%)
5 Hot Earnings Charts This Week

Finance, travel and healthcare. How will these industries survive the coronavirus crisis?

EXAS : 85.88 (+2.37%)
PYPL : 155.01 (+4.18%)
SQ : 81.08 (+1.83%)
BKNG : 1,639.42 (-0.58%)
UBER : 36.32 (+6.35%)
How Hard Will Coronavirus Hit Zimmer Biomet (Zbh) Q1 Earnings?

Zimmer Biomet (ZBH) may have registered improved performances within its Hips and Knees arms due to the nature of the businesses.

HAE : 109.68 (-0.81%)
EXAS : 85.88 (+2.37%)
ZBH : 126.34 (-1.29%)
ACB : 14.08 (-8.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Trade EXAS with:

Business Summary

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in...

See More

Key Turning Points

2nd Resistance Point 88.59
1st Resistance Point 87.23
Last Price 85.88
1st Support Level 83.29
2nd Support Level 80.71

See More

52-Week High 123.99
Fibonacci 61.8% 90.09
Last Price 85.88
Fibonacci 50% 79.62
Fibonacci 38.2% 69.15
52-Week Low 35.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar